Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nuvation Bio Inc. Class A Common Stock (NY:NUVB)

5.635 +0.175 (+3.21%)
Streaming Delayed Price Updated: 3:16 PM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Nuvation Bio Inc. Class A Common Stock

< Previous 1 2 3 Next >
Nuvation Bio Stock Logs Its Best Session Ever: Wall Street Turns Bullish On Lung Cancer Drug’s Blockbuster Debut ↗
Via Stocktwits
News headline image
Nuvation Bio (NUVB) Soars on IBTROZI's Blockbuster Launch and Stellar Q3 2025 Performance
Boston, MA – November 19, 2025 – Nuvation Bio Inc. (NASDAQ: NUVB) has captured the financial spotlight, witnessing a remarkable 47.71% surge in its stock price following a stellar third-quarter 2025... 
Via MarketMinute
News headline image
Which stocks are moving on Wednesday? ↗
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Earnings Scheduled For November 3, 2025 ↗
 
Via Benzinga
News headline image
4 Analysts Assess Nuvation Bio: What You Need To Know ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Nuvation Bio (NUVB) Q3 2025 Earnings Transcript ↗
Nuvation Bio (NUVB) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan — Here's What to Know About the Stock ↗
Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan — Here's What to Know About the Stock 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why Nuvation Bio Stock Is Skyrocketing Today ↗
The bulls are lining up on Wall Street for this up-and-coming biotech stock. 
Via The Motley Fool
News headline image
Analyst Expectations For Nuvation Bio's Future ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 7, 2025 ↗
 
Via Benzinga
News headline image
United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Guidewire Software, Samsara, Zumiez And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Top 2 Health Care Stocks That May Plunge This Month ↗
 
Via Benzinga
News headline image
NUVB Sales Jump 1,043% on Drug Launch ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Nuvation Bio Inc (NYSE:NUVB) Reports Mixed Q2 2025 Results with Strong Revenue Beat but Cautious Market Reaction ↗
Nuvation Bio (NUVB) reported Q2 2025 results with a massive revenue beat ($4.83M vs. $364K est.) driven by IBTROZI launch, but EPS met expectations (-$0.17). Cash at $607.7M, pipeline progressing. 
Via Chartmill
News headline image
Nuvation Bio's Ibtrozi For ROS1-Positive Lung Cancer Wins FDA Approval ↗
FDA approves Ibtrozi for ROS1+ non-small cell lung cancer based on data from over 300 patients in two pivotal trials showing high response rates. 
Via Benzinga
News headline image
Apple To $280? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Top 4 Health Care Stocks That May Plunge This Quarter ↗
 
Via Benzinga
News headline image
Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data ↗
Nuvation Bio halts its NUV-868 BET inhibitor program after Phase 1 study analysis. The decision impacts solid tumor treatments in ovarian, pancreatic, and mCRPC cancers, focusing instead on late-stage... 
Via Benzinga
News headline image
NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying ↗
 
Via Benzinga
News headline image
NUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024 ↗
NUVB stock results show that Nuvation Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
ProfoundBio Discovers The Joys Of Having A Wealthy Owner ↗
Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a... 
Via Benzinga
News headline image
Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.